Ozcan Basaran Profile
Ozcan Basaran

@ozcan__basaran

Followers
790
Following
1K
Media
75
Statuses
194

Dr. Ozcan Basaran, MD, FESC, Professor of Cardiology at MSKU, Atherosclerosis and Preventive Cardiology Working Group of TSC, EAPC SoMe Ambassador

Muğla, Türkiye
Joined February 2012
Don't wanna be here? Send us removal request.
@ozcan__basaran
Ozcan Basaran
6 months
TKD Webinar // Pnömokok Bağışıklamasında Güncel Aşı Yaklaşımları - 25 Şubat Salı 20:30
Tweet media one
0
0
2
@ozcan__basaran
Ozcan Basaran
8 months
Viviane Conraads Outstanding Achievement Award!. Last call for candidates!.EAPC honours a young researcher under 45, for significant contribution to preventive cardiology every year. This is your chance to gain recognition! Apply by 31 December.
0
1
0
@grok
Grok
6 days
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
403
654
3K
@ozcan__basaran
Ozcan Basaran
11 months
RT @TKDResmi: Değerli Üyemiz, 12 Eylül Perşembe günü saat 20:30’da ESC 2024 Kronik Koroner Sendromlar Kılavuzu başlıklı bir webinar gerçekl….
0
1
0
@ozcan__basaran
Ozcan Basaran
1 year
Last but not least. The last day of #ESCCongress2024 is about to begin.Good morning early birds!
Tweet media one
0
0
11
@ozcan__basaran
Ozcan Basaran
1 year
🚨 Study links workplace sexual harassment to higher cardiometabolic disease risk in 88K+ Swedish workers. 4.8% reported harassment (1.9% men, 7.5% women). Let’s ensure safer workspaces! 💪 #workplacesafety @Savvashad @GawalkoM @mspartalis5 @sampathkpt.
0
0
0
@ozcan__basaran
Ozcan Basaran
1 year
RT @GawalkoMonika: The #ESCCongress2024 is approaching! Extend your stay in London 🇬🇧with the #EAPC Sports Cardiology course!. 🗓️03.09 ⏰8:5….
0
10
0
@ozcan__basaran
Ozcan Basaran
1 year
A short story of CETP inhibitors. Why did they fail? What are the potential therapeutic options? Is it increasing HDL-C or decreasing LDL-C? Listen to our podcast with @JohnKastelein on Spotify. @TKDsosyal @drbarisgungor @society_eas.
Tweet card summary image
open.spotify.com
Türk Kardiyoloji Derneği Podcast Serisi · Episode
0
3
10
@ozcan__basaran
Ozcan Basaran
1 year
The EAPC is currently seeking to define the educational requirements of healthcare professionals, focusing on dyslipidaemias, cardiometabolic syndrome - diabetes - obesity, hypertension - kidney and CVD, and hypertrophic cardiomyopathy; Survey here
Tweet media one
0
0
6
@ozcan__basaran
Ozcan Basaran
1 year
New study links genetics & air pollution to ↑ AAA risk! Both play a role, but together the risk is much higher. Time to reduce air pollution & protect those most susceptible. #EAPCYoung @PeroneFrancesco @PTBuketAkinci @GawalkoMonika @VaidaSileikiene
Tweet media one
0
3
11
@ozcan__basaran
Ozcan Basaran
1 year
Last but not least, the last session of #EASCongress2024 Is CAC primary or secondary prevention? ⁦@LaleTokgozoglu⁩ ⁦@MeralKayikcoglu⁩ ⁦@Dr_IbrahimAltun⁩ ⁦@TKDsosyal
Tweet media one
Tweet media two
0
3
11
@ozcan__basaran
Ozcan Basaran
1 year
Coronary Calcium Score (>300) = same CVD risk as established heart disease! #EASCongress2024 #CAC #CCT@MeralKayikcoglu⁩ ⁦@Dr_IbrahimAltun
Tweet media one
0
2
14
@ozcan__basaran
Ozcan Basaran
1 year
Polygenic risk scores could play a bigger role in identifying people at risk for CVD! #EASCongress2024 #PRS
Tweet media one
0
2
8
@ozcan__basaran
Ozcan Basaran
1 year
CAC score is the most strong risk modifier beyond classical risk factors #EASCongress2024@maryamkavousi⁩ ⁦@Dr_IbrahimAltun⁩ ⁦@TKDsosyal
Tweet media one
1
2
7
@ozcan__basaran
Ozcan Basaran
1 year
Barriers of smoking cessation, there are many challenges along the way. #EASCongress2024 #MyEAS2024@LaleTokgozoglu⁩ ⁦@maryamkavousi⁩ ⁦@MeralKayikcoglu
Tweet media one
0
3
5
@ozcan__basaran
Ozcan Basaran
1 year
Third day of #EASCongress2024 has just begun! #MyEAS2024@LaleTokgozoglu⁩ ⁦@ProfKausikRay⁩ ⁦@MeralKayikcoglu
Tweet media one
0
2
4
@ozcan__basaran
Ozcan Basaran
1 year
CETP inhibition to lower LDL-C, will obicetrapib change the game? #EASCongress2024@ProfKausikRay⁩ ⁦@JohnKastelein⁩ ⁦@maciejbanach
Tweet media one
1
5
17
@ozcan__basaran
Ozcan Basaran
1 year
Why should I measure Lp(a)? #EASCongress2024 ⁦⁦@TKDsosyal#Lp(a) #atherosclerosis #risk
Tweet media one
2
2
11
@ozcan__basaran
Ozcan Basaran
1 year
Ebbinghaus-Ole study. No safety concerns regarding neurocognitive dysfunction with very low LDL-C levels. #EASCongress2024@TKDsosyal⁩ ⁦@LaleTokgozoglu⁩ ⁦@MeralKayikcoglu
Tweet media one
0
6
12
@ozcan__basaran
Ozcan Basaran
1 year
92nd EAS congress has just started! Time for great science. #EASCongress2024@EASCongress⁩ ⁦@society_eas⁩ ⁦@LaleTokgozoglu⁩ ⁦@stefano_romeo76⁩ ⁦@MeralKayikcoglu
Tweet media one
0
6
17